Show simple item record

dc.contributor.authorNeale, Holly
dc.contributor.authorHawryluk, Elena B.
dc.date2022-08-11T08:08:11.000
dc.date.accessioned2022-08-23T15:45:18Z
dc.date.available2022-08-23T15:45:18Z
dc.date.issued2021-10-01
dc.date.submitted2021-09-02
dc.identifier.citation<p>Neale H, Hawryluk EB. COVID-19 Pediatric Dermatology. Dermatol Clin. 2021 Oct;39(4):505-519. doi: 10.1016/j.det.2021.05.012. Epub 2021 May 31. PMID: 34556241; PMCID: PMC8165089.</p>
dc.identifier.doi10.1016/j.det.2021.05.012
dc.identifier.pmid34556241
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27497
dc.description.abstractChildren are a unique subset of patients in relation to the COVID-19 pandemic, often presenting asymptomatically, mildly, or atypically. Manifestations of the skin may be a primary (or the only) presenting sign. Recognizing cutaneous manifestations of COVID-19 in the pediatric population is important to guiding precautions, testing, and management for patients and close contacts. Whereas some dermatologic signs in children overlap with those in adults, other skin findings are reported with higher frequency in children and may be clues to multisystemic sequelae. This article describes presentation, pathophysiologic theories, and management strategies for cutaneous manifestations of COVID-19 in children.
dc.language.isoen_US
dc.relation<p><a href="https://pubmed.ncbi.nlm.nih.gov/34556241/" target="_blank" title="view article in PubMed">View article in PubMed</a></p>
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165089/
dc.subjectMIS-C
dc.subjectPediatric dermatology
dc.subjectCOVID-19 children
dc.subjectPerniosis
dc.subjectPernio-like lesions
dc.subjectDermatology
dc.subjectInfectious Disease
dc.subjectPediatrics
dc.subjectSkin and Connective Tissue Diseases
dc.subjectVirus Diseases
dc.titleCOVID-19 Pediatric Dermatology
dc.typeJournal Article
dc.source.journaltitleDermatologic Clinics
dc.source.volume39
dc.source.issue4
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/covid19/299
dc.identifier.contextkey24635909
html.description.abstract<p>Children are a unique subset of patients in relation to the COVID-19 pandemic, often presenting asymptomatically, mildly, or atypically. Manifestations of the skin may be a primary (or the only) presenting sign. Recognizing cutaneous manifestations of COVID-19 in the pediatric population is important to guiding precautions, testing, and management for patients and close contacts. Whereas some dermatologic signs in children overlap with those in adults, other skin findings are reported with higher frequency in children and may be clues to multisystemic sequelae. This article describes presentation, pathophysiologic theories, and management strategies for cutaneous manifestations of COVID-19 in children.</p>
dc.identifier.submissionpathcovid19/299
dc.contributor.departmentSchool of Medicine
dc.source.pages505-519


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record